METHUSELAH ARCHIVE SOURCES / FDA-NLM-NOTICE-JUDGMENT-2389-GHADIALI-1949

2389. Misbranding of Spectro-Chrome. U.S. v. Dinshah P. Ghadiali and Dinshah Spectro-Chrome Institute

primary document · 1949
type:primary document
year:1949
citation:U.S. Food and Drug Administration, Notice of Judgment 2389, "Misbranding of Spectro-Chrome," FDA Notices of Judgment Collection, 1908-1966 (District of New Jersey), issued April 1949; digitized by the National Library of Medicine.
LINK
https://fdanj.nlm.nih.gov/catalog/ddnj02389
SUMMARY
Official U.S. FDA Notice of Judgment (case 2389), digitized and hosted by the National Library of Medicine, verified by direct fetch. Names defendants Dinshah P. Ghadiali and Dinshah Spectro-Chrome Institute (Malaga, N.J.); records seven counts of misbranding Spectro-Chrome products shipped from New Jersey to New York, Pennsylvania, Ohio, Wisconsin, Michigan, Missouri, and Delaware; records seizure dates September 3, 1942 and July 9, 1945; records a jury trial, verdict of guilty, the Institute fined $12,000 and Ghadiali fined $8,000, one year imprisonment on each of the first three counts with execution suspended, five years' probation, and imposition of sentence on the last four counts suspended; and records that the judgment was affirmed on appeal to the U.S. Court of Appeals and that the Supreme Court denied a petition for a writ of certiorari. Court: District of New Jersey. Used as the primary regulatory/court record establishing the case's federal misbranding conviction, sentence, and exhausted appeal.
NOTES

The FDA’s own official Notice of Judgment for the criminal misbranding case against Dinshah P. Ghadiali and the Dinshah Spectro-Chrome Institute: verdict, sentence, fines, and appellate history, digitized by the National Library of Medicine.